
This research report titled “Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017)” provides details about various autologous cell based treatments and their application areas. Every health regulatory bodies will be expecting companies and universities to develop therapy treatments, which are Safer, Affordable, Robust, Rapid, Easy to use, Effective and Deliverable to the end user. Autologous stem cell transplantation for particular application areas is safe experiencing robust growth and has minimal steps of procedure to follow and is rapid in deriving the results. The sources for autologous stem cell therapy are Mesenchymal stem cells, Hematopoietic stem cells, Chondrocytes and so on. Currently, the cost of the treatments is not affordable however, by the intrusion of government bodies, this mode of treatment will certainly experience an immense market growth.